Delivery Order SPE2DB24D2012-SPE2DB25FBVUQ

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,584.09 firm-fixed-price delivery order is for the supply of 4,568,239,259 units of Progesterone 200 mg capsules in 100-count packages. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,359.89 firm fixed-price delivery order is for the supply of 4,568,236,190 units of a 200 mg progesterone capsule product. The contract has an ultimate completion date of May 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with...
This federal contract award, valued at $22,962.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567908583 - Progesterone 200 mg Capsule 100s, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 15, 2025. The contract is not set aside for any specific business category. Amerisourcebergen...
This federal contract award, valued at $18,557.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567752016 - Progesterone 200 mg Capsule 100s. This appears to be a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 1, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award, valued at $11,961.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,925,357 units of Progesterone 200 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Defense Logistics Agency (DLA) awarded this $33,274.46 Firm Fixed Price Delivery Order for 4,567,038,407 units of Progesterone 200 mg Capsule 100s. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order with a Firm Fixed Price, is for the supply of 4,568,062,572 units of a 200 mg Progesterone capsule in 100-count packages. The contract has a ceiling value of $1,244.25 and a period of performance through April 29, 2025. This award is not a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,019.74 Delivery Order contract is for the supply of 4,567,600 units of Progesterone 200 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of March 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Progesterone 200 mg capsules, a pharmaceutical product, with a ceiling value of $12,455.23. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 1, 2025. The contract is not set aside and is open to competition....
This federal contract award, valued at $1,321.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568078090 - Progesterone 200 mg Capsules, 100s, and has an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB25FBVUQ
    Delivery Order

This federal contract award, with ID SPE2DB24D2012|SPE2DB25FBVUQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, has a firm fixed price and a ceiling value of $31,240.19. It is for the delivery of 4567943116 - Progesterone 200 mg Capsule 100s, and has an ultimate completion date of April 17, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

This contract award is not set-aside and is open to full and open competition.

Generated 7/16/25, 12:09 PM